Profile picture

Professor Junichi Ishii

Fujita Health University Second Hospital, Nagoya (Japan)
Follow
Logo ESC

Contributor content

Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
Presentation
Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
Circulating concentration of presepsin improves early prediction of short-term mortality in patients treated at medical cardiac intensive care units
Presentation
Circulating concentration of presepsin improves early prediction of short-term mortality in patients treated at medical cardiac intensive care units
Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
Presentation
Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
Presentation
Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units

ESC 365 is supported by